Exchange: NASDAQ
Industry: Pharmaceuticals & Biotechnology
Last Trade: 4:00 PM ET 5/24/2012
Last 10 Quotes:
What's This?
| Most Recent Quarter ($) | Same Quarter Last Year ($) | % Change | |
| EPS, Pro Forma | -0.84 | -0.61 | 37.40 |
| EPS, GAAP | -0.88 | -0.78 | -0.78 |
| Consensus Estimate | -0.54 | -0.14 | 280.03 |
| Trailing 12 Months | Year-Earlier Period | % Change | |
| EPS, Pro Forma | 0.28 | -0.31 | -192.39 |
| EPS, GAAP | 1.19 | -1.35 | -187.75 |
| Consensus Estimate | 0.31 | 0.87 | -64.78 |
| ONXX | Industry Average | |
| P/E (TTM) | 42.81 | NA |
| P/E (Forward) | 0.00 | NA |
| PEG Ratio | 0.00 | 2.17 |
| Price/Sales | 6.18 | 4.18 |
| Beta | 0.84 | 0.62 |
| 3:16 AM | 5/22/2012 | Bayer: Nexavar Lung Cancer Phase III Study Misses Primary Endpoint |
| 5/18/2012 | An Early Look at 2012 ASCO Biotech Cancer Stocks (DNDN, LLY, AMGN, ARIA, ARQL, ARRY, AVEO, BVTI, ABPI, BMY, CLDX, CYTR, CYCC, GALE, EXEL, GNBT, GHDX, IMGN, MYGN, NKTR, NLNK, ONXX, OPTR, PCYC, SGEN, SNSS, SNTA) (24/7 Wall St) |
| 5/3/2012 | Top Analyst Upgrades & Downgrades (ALGN, BHI, CACI, CAB, CHK, DVA, GMCR, LVLT, MSCI, ONXX, PCLN, QCOM, QIHU, CRM, TTM) (24/7 Wall St) |
| 3/24/2012 | Health Care's Surprising Vigor (Barrons.com) |
| 2/29/2012 | Not necessarily. (The Motley Fool) |
![[sm061210things]](http://s.wsj.net/public/resources/images/PF-AC562_sm0612_C_20120514113337.jpg)
![[sm0612wedding4]](http://s.wsj.net/public/resources/images/PF-AC579_sm0612_C_20120515172853.jpg)
![[sm0612strat]](http://s.wsj.net/public/resources/images/PF-AC580_sm0612_C_20120515180019.jpg)
![[sm0612roi]](http://s.wsj.net/public/resources/images/PF-AC573_sm0612_C_20120515125902.jpg)
